Changes in primary endpoints in cancer trials.

Q4 Medicine

Drug and Therapeutics Bulletin Pub Date : 2023-12-27 DOI:10.1136/dtb.2023.000064

引用次数: 0

Abstract

Overview of: Florez MA, Jaoude JA, Patel RR, et al. Incidence of primary end point changes among active cancer phase 3 randomized clinical trials.JAMA Netw Open2023;6:e2313819.

查看原文本刊更多论文

癌症试验主要终点的变化。

概述：Florez MA, Jaoude JA, Patel RR, et al. Inidence of primary end point changes among active cancer phase 3 randomized clinical trials.JAMA Netw Open2023;6:e2313819.

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Drug and Therapeutics Bulletin Medicine-Pharmacology (medical)

CiteScore

0.80

自引率

0.00%

发文量